YORK, UK - Eden Research Plc (AIM: EDEN), the AIM-listed biopesticide and encapsulation company, announced in a press release that it has been granted a Patent from the Korean Intellectual Property Office covering the composition and use of its key active terpene-based ingredients (Patent No. 10-1478012).

The patent specifically covers, "Compositions and Methods Comprising Terpenes or Terpene Mixtures selected from Thymol, Eugenol, Geraniol, Citral, and L-Carvone." This grant widens the patent coverage in South Korea from the patent announced in July 2014 which encompassed the application of Eden's encapsulation and terpene technology for killing mites.

Sean Smith Managing Director of Eden comments: "Our intellectual property is a key value driver for the business and its licensees and so the continued widening of our patent protection across multiple geographies is an important goal for the team. As we've mentioned before, the crop protection market in South Korea is substantial and this additional patent offers us excellent protection as we continue to move closer to the commercial launch of products using our technologies worldwide."